Cargando…
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
BACKGROUND AND AIMS: Morbidity and mortality from coronavirus disease 2019 (COVID-19) is higher among people with diabetes mellitus (DM), hypertension, and cardiovascular disease (CVD). Statins are used in the majority of people with DM and CVD. This mini-review discusses the current understanding o...
Autores principales: | Subir, Ray, Jagat J, Mukherjee, Kalyan K, Gangopadhyay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Diabetes India. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352102/ https://www.ncbi.nlm.nih.gov/pubmed/32683320 http://dx.doi.org/10.1016/j.dsx.2020.07.011 |
Ejemplares similares
-
Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane?
por: Jagat J, Mukherjee, et al.
Publicado: (2020) -
Management of diabetes in patients with COVID-19
por: Mukherjee, Jagat J, et al.
Publicado: (2020) -
Letter in response to the article: Pros and cons for use of statins in 59 people with coronavirus disease-19 (COVID-19)(Ray, S et al.)
por: Zhao, Tie, et al.
Publicado: (2021) -
Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
por: Al‐kuraishy, Hayder M., et al.
Publicado: (2023) -
Aspirin in COVID-19: Pros and Cons
por: Zareef, Rana, et al.
Publicado: (2022)